Next, we investigated whether cell-mediated immune (CMI) responses to SARS-CoV-2 differed between Lepr-deficient, T2DM and lean mice, by analyzing murine splenic T-lymphocyte (CD4+ and CD8+)-specific responses. This evidence concerns the gene CD4 and type 2 diabetes mellitus.